Risk factors for left ventricular hypertrophy: role of Na(+)-Li+ countertransport

Area of Science:

• Cardiology
• Hypertension Research
• Cellular Physiology

Background:

• Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular mortality in patients with essential hypertension (EH).
• The underlying mechanisms and risk factors contributing to LVH development in EH are complex and not fully elucidated.
• Identifying novel markers for LVH could improve risk stratification and patient management.

Purpose of the Study:

• To investigate potential risk factors for LVH in a cohort of nonobese patients with essential hypertension.
• To assess the association between erythrocyte ion transport activity, intracellular sodium levels, and insulin sensitivity with left ventricular mass index (LVMI).
• To identify independent predictors of LVH in essential hypertension.

Main Methods:

• A cross-sectional study involving 28 nonobese patients with essential hypertension.
• Analysis of erythrocyte ion transport parameters: Vmax of NaLi countertransport, NaKCl cotransport, NaK-pump, and Na-leak Kp Na.
• Measurement of intracellular sodium and insulin sensitivity index, with LVMI as the dependent variable.

Main Results:

• Age, duration of EH, and Vmax of NaLi countertransport were significantly associated with LVMI in univariate analysis.
• Stepwise multiple regression identified age, duration of EH, and Vmax of NaLi countertransport as independent predictors of LVMI (R2 = 0.581, P = 0.0001).
• Specifically, Vmax of NaLi countertransport showed a significant independent association with LVMI (P = 0.032).

Conclusions:

• The NaLi countertransport, a mode of NaH exchanger activity, may serve as a valuable biomarker for LVH in essential hypertension.
• This finding suggests that NaLi countertransport activity could indicate increased cardiovascular risk in hypertensive individuals.
• Further research into the role of NaLi countertransport in cellular growth and LVH is warranted.